Cayman Chemical GInsenosIde Rg1 25mg
A steroid glycoside with diverse biological activities; decreases blood glucose, IL-1β, and IL-18 levels, increases insulin secretion, and inhibits hepatic and pancreatic activation of the NLRP3 inflammasome in a mouse model of STZ-induced diabetes at 10, 20, and 40 mg/kg; facilitates fear extinction and decreases immobility time in the tail-suspension and forced swim tests in a mouse model of single-prolonged stress-induced PTSD; decreases hepatic ALT and AST levels and attenuates hepatic steatosis in a mouse model of ethanol-induced hepatitis; decreases the abundance of Bacteroidetes in the large intestine, cortical neuron apoptosis, and latency to the platform in the Morris water maze in a tree shrew model of Aβ (25-35)-induced Alzheimer’s disease